Thank you, Mr. Chair.
Thank you to the witnesses for their illuminating insights. You're giving us a lot of food for thought.
Since I have only three and a half minutes left, my questions will be for Dr. Freeland.
Dr. Freeland, I understand your association has been quite interested in the issue of access to MAID for mental disorders and you co-chair a committee—a working group—on this.
Can you tell us how many members are on that committee? Did your subgroup study the report from the task force?